Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14

1.

Master protocol trial design for efficient and rational evaluation of novel therapeutic oncology devices.

Bitterman DS, Cagney DN, Singer L, Nguyen PL, Catalano PJ, Mak RH.

J Natl Cancer Inst. 2019 Aug 27. pii: djz167. doi: 10.1093/jnci/djz167. [Epub ahead of print]

PMID:
31504680
2.

Revisiting the Role of Radiation Therapy for Pediatric Low-Grade Glioma.

Bitterman DS, MacDonald SM, Yock TI, Tarbell NJ, Wright KD, Chi SN, Marcus KJ, Haas-Kogan DA.

J Clin Oncol. 2019 Sep 9:JCO1901270. doi: 10.1200/JCO.19.01270. [Epub ahead of print] No abstract available.

PMID:
31498029
3.

Use of Natural Language Processing to Extract Clinical Cancer Phenotypes from Electronic Medical Records.

Savova GK, Danciu I, Alamudun F, Miller T, Lin C, Bitterman DS, Tourassi G, Warner JL.

Cancer Res. 2019 Nov 1;79(21):5463-5470. doi: 10.1158/0008-5472.CAN-19-0579. Epub 2019 Aug 8. Review.

PMID:
31395609
4.

A Central Role of Radiation Therapy in Central Nervous System Germinoma.

Bitterman DS, Chi SN, Haas-Kogan DA.

Int J Radiat Oncol Biol Phys. 2019 Aug 1;104(5):970-971. doi: 10.1016/j.ijrobp.2019.05.020. No abstract available.

PMID:
31327428
5.

Cardiac Radiation Dose, Cardiac Disease, and Mortality in Patients With Lung Cancer.

Atkins KM, Rawal B, Chaunzwa TL, Lamba N, Bitterman DS, Williams CL, Kozono DE, Baldini EH, Chen AB, Nguyen PL, D'Amico AV, Nohria A, Hoffmann U, Aerts HJWL, Mak RH.

J Am Coll Cardiol. 2019 Jun 18;73(23):2976-2987. doi: 10.1016/j.jacc.2019.03.500.

6.

Patterns of Care and Outcomes of Definitive External Beam Radiotherapy and Radioembolization for Localized Hepatocellular Carcinoma: A Propensity Score-adjusted Analysis.

Bitterman DS, Sanford NN, Niemierko A, Mahal BA, Qadan M, Ganguli S, Blaszkowsky LS, Zhu AX, Hong TS, Devlin PM, Goyal L, Wo JY.

Am J Clin Oncol. 2019 Jul;42(7):564-572. doi: 10.1097/COC.0000000000000560.

PMID:
31166209
7.

Towards a standard of care in oncology for transgender patients.

Burns ZT, Bitterman DS, Liu KX, Terezakis SA, Neira PM, Haas-Kogan DA.

Lancet Oncol. 2019 Mar;20(3):331-333. doi: 10.1016/S1470-2045(18)30942-2. No abstract available.

PMID:
30842045
8.

Achieving gender equity in the radiation oncology physician workforce.

Holliday EB, Siker M, Chapman CH, Jagsi R, Bitterman DS, Ahmed AA, Winkfield K, Kelly M, Tarbell NJ, Deville C Jr.

Adv Radiat Oncol. 2018 Oct 21;3(4):478-483. doi: 10.1016/j.adro.2018.09.003. eCollection 2018 Oct-Dec. Erratum in: Adv Radiat Oncol. 2018 Nov 02;4(1):210.

9.

Factors affecting local regrowth after watch and wait for patients with a clinical complete response following chemoradiotherapy in rectal cancer (InterCoRe consortium): an individual participant data meta-analysis.

Chadi SA, Malcomson L, Ensor J, Riley RD, Vaccaro CA, Rossi GL, Daniels IR, Smart NJ, Osborne ME, Beets GL, Maas M, Bitterman DS, Du K, Gollins S, Sun Myint A, Smith FM, Saunders MP, Scott N, O'Dwyer ST, de Castro Araujo RO, Valadao M, Lopes A, Hsiao CW, Lai CL, Smith RK, Paulson EC, Appelt A, Jakobsen A, Wexner SD, Habr-Gama A, Sao Julião G, Perez R, Renehan AG.

Lancet Gastroenterol Hepatol. 2018 Dec;3(12):825-836. doi: 10.1016/S2468-1253(18)30301-7. Epub 2018 Oct 12.

10.

Radiation Safety and Cardiovascular Implantable Electronic Devices.

Bitterman DS, Zei PC, Mak RH.

Int J Radiat Oncol Biol Phys. 2018 Oct 1;102(2):243-246. doi: 10.1016/j.ijrobp.2018.05.071. No abstract available.

PMID:
30191855
11.

Predictors of Complete Response and Disease Recurrence Following Chemoradiation for Rectal Cancer.

Bitterman DS, Resende Salgado L, Moore HG, Sanfilippo NJ, Gu P, Hatzaras I, Du KL.

Front Oncol. 2015 Dec 22;5:286. doi: 10.3389/fonc.2015.00286. eCollection 2015.

12.

Comparison of anal cancer outcomes in public and private hospital patients treated at a single radiation oncology center.

Bitterman DS, Grew D, Gu P, Cohen RF, Sanfilippo NJ, Leichman CG, Leichman LP, Moore HG, Gold HT, Du KL.

J Gastrointest Oncol. 2015 Oct;6(5):524-33. doi: 10.3978/j.issn.2078-6891.2015.061.

13.

MAPK signaling cascades mediate distinct glucocorticoid resistance mechanisms in pediatric leukemia.

Jones CL, Gearheart CM, Fosmire S, Delgado-Martin C, Evensen NA, Bride K, Waanders AJ, Pais F, Wang J, Bhatla T, Bitterman DS, de Rijk SR, Bourgeois W, Dandekar S, Park E, Burleson TM, Madhusoodhan PP, Teachey DT, Raetz EA, Hermiston ML, Müschen M, Loh ML, Hunger SP, Zhang J, Garabedian MJ, Porter CC, Carroll WL.

Blood. 2015 Nov 5;126(19):2202-12. doi: 10.1182/blood-2015-04-639138. Epub 2015 Aug 31.

14.

Loss of TBL1XR1 disrupts glucocorticoid receptor recruitment to chromatin and results in glucocorticoid resistance in a B-lymphoblastic leukemia model.

Jones CL, Bhatla T, Blum R, Wang J, Paugh SW, Wen X, Bourgeois W, Bitterman DS, Raetz EA, Morrison DJ, Teachey DT, Evans WE, Garabedian MJ, Carroll WL.

J Biol Chem. 2014 Jul 25;289(30):20502-15.

Supplemental Content

Loading ...
Support Center